Low-Dose Naltrexone for Ankylosing Spondylitis: Clinical Evidence and Protocol
How LDN modulates neuroinflammation and opioid-growth-factor signaling in ankylosing spondylitis. Evidence review, dosing protocol, and what patients can expect — from a physician perspective.